Proglumetacin
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | M01AB14 (WHO) |
Pharmacokinetic data | |
Metabolism | Hepatic. Undergoes enterohepatic recirculation |
Identifiers | |
|
|
Synonyms | 3-[4-[2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyethyl]piperazin-1-yl]propyl 4-(benzoylamino)-5-(dipropylamino)-5-oxopentanoate |
CAS Number | 57132-53-3 59209-40-4 |
PubChem (CID) | 4921 |
ChemSpider | 4752 ![]() |
UNII | FV919079LU ![]() |
ChEBI | CHEBI:76263 |
Chemical and physical data | |
Formula | C46H58ClN5O8 |
Molar mass | 844.43442 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Proglumetacin (usually as the maleate salt, trade names Afloxan, Protaxon and Proxil) is a non-steroidal anti-inflammatory drug. It is metabolized in the body to indometacin and proglumide,[1] a drug with antisecretory effects that helps prevent injury to the stomach lining.
References[edit]
![]() |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |